Thursday, February 15, 2024

🌎 Super Micro Computer Initiated, Ingredion Upgraded, Cleveland-Cliffs Downgraded and more...

Ratings changes for Super Micro Computer, CRISPR Therapeutics, SSR Mining, NVIDIA, Sanofi, Coinbase Global, Monte Rosa Therapeutics and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
February 15th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
S&P 500's surge to new highs: Bull trap hiding in plain sight?
Musk pushes forward on transfer of legal home for SpaceX from Delaware, to Texas
This Stock Could Go Up 66% or More. (Chaikin Analytics)
Impinj stock surges on strong earnings and guidance
Cleveland-Cliffs to shutter West Virginia tin plant and lay off 900 after tariff ruling
Pfizer at 10-year support: Is it a massive buy opportunity?
Ford CEO says company will rethink where it builds vehicles after last year's autoworkers strike
Wall Street Legend: "Buy this A.I. stock NOW" (Chaikin Analytics)
Restaurant Brands expands its Burger King franchise empire
Greek farmers decide to take their protests to Athens and expand roadblock campaign
Gene therapy: Why does it cost millions for a single treatment?
Treasury promoting new rules to stop money laundering ahead of Europe meetings
Evolution from AI to ASI, What Investors Need to Know
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Air Products and Chemicals (NYSE:APD) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $264.00 price target on the stock. This represents a 16.5% upside from the current price of $226.63.
  • Coinbase Global (NASDAQ:COIN) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $80.00 price target on the stock. This represents a 52.1% downside from the current price of $167.02.
  • Entegris (NASDAQ:ENTG) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock. This represents a 12.0% upside from the current price of $133.88.
  • Eversource Energy (NYSE:ES) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $62.00 price target on the stock, up previously from $54.00. This represents a 7.3% upside from the current price of $57.78.
  • Inogen (NASDAQ:INGN) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $9.91.
  • Ingredion (NYSE:INGR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $135.00 price target on the stock, up previously from $122.00. This represents a 19.1% upside from the current price of $113.35.
  • Medpace (NASDAQ:MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00. This represents a 15.7% upside from the current price of $390.59.
  • Manulife Financial (NYSE:MFC) (TSE:MFC) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $31.00. This represents a 45.3% upside from the current price of $24.09.
  • Molina Healthcare (NYSE:MOH) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $420.00 price target on the stock, up previously from $367.00. This represents a 5.5% upside from the current price of $398.02.
  • Outlook Therapeutics (NASDAQ:OTLK) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating. They now have a $3.00 price target on the stock. This represents a 533.7% upside from the current price of $0.47.
  • Similarweb (NYSE:SMWB) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock, up previously from $6.00. This represents a 28.4% upside from the current price of $7.79.
  • Teradyne (NASDAQ:TER) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $100.00 price target on the stock, up previously from $90.00. This represents a 2.2% downside from the current price of $102.23.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Akamai Technologies (NASDAQ:AKAM) was downgraded by analysts at HSBC Holdings plc from a "hold" rating to a "reduce" rating. They now have a $96.00 price target on the stock, down previously from $109.00. This represents a 15.0% downside from the current price of $112.97.
  • Cleveland-Cliffs (NYSE:CLF) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $20.00 price target on the stock, down previously from $21.50. This represents a 1.2% upside from the current price of $19.77.
  • Comcast (NASDAQ:CMCSA) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating. They now have a $44.00 price target on the stock, down previously from $50.00. This represents a 5.1% upside from the current price of $41.88.
  • Charles River Laboratories International (NYSE:CRL) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $240.15.
  • Fastly (NYSE:FSLY) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $20.00 price target on the stock. This represents a 20.3% upside from the current price of $16.63.
  • Generac (NYSE:GNRC) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $119.08.
  • IPG Photonics (NASDAQ:IPGP) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $74.00 price target on the stock, down previously from $111.00. This represents a 17.3% downside from the current price of $89.45.
  • IQVIA (NYSE:IQV) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $240.65.
  • Keysight Technologies (NYSE:KEYS) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $184.00. This represents a 9.7% upside from the current price of $154.94.
  • Owens Corning (NYSE:OC) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $154.00 price target on the stock, down previously from $163.00. This represents a 8.8% upside from the current price of $141.56.
  • Snowflake (NYSE:SNOW) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $214.00 price target on the stock, up previously from $212.00. This represents a 7.4% downside from the current price of $231.02.
  • Sony Group (NYSE:SONY) was downgraded by analysts at Macquarie from an "outperform" rating to a "neutral" rating.The current price is $91.31.
  • SSR Mining (NASDAQ:SSRM) (TSE:SSO) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $6.00 price target on the stock, down previously from $14.00. This represents a 26.3% upside from the current price of $4.75.
  • Twilio (NYSE:TWLO) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $66.00 price target on the stock. This represents a 6.4% upside from the current price of $62.01.
  • Westinghouse Air Brake Technologies (NYSE:WAB) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating. They now have a $135.00 price target on the stock. This represents a 1.0% upside from the current price of $133.63.
  • United States Steel (NYSE:X) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $51.00 price target on the stock, up previously from $40.00. This represents a 12.0% upside from the current price of $45.55.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $148.58.
  • Alpine Immune Sciences (NASDAQ:ALPN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $44.00 price target on the stock. This represents a 49.2% upside from the current price of $29.50.
  • argenx (NASDAQ:ARGX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $392.35.
  • Cullinan Oncology (NASDAQ:CGEM) is now covered by analysts at Wedbush. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 65.2% upside from the current price of $18.16.
  • CRISPR Therapeutics (NASDAQ:CRSP) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $83.80.
  • CervoMed (NASDAQ:CRVO) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $50.00 price target on the stock. This represents a 211.3% upside from the current price of $16.06.
  • CervoMed (NASDAQ:CRVO) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $50.00 price target on the stock. This represents a 211.3% upside from the current price of $16.06.
  • Cisco Systems (NASDAQ:CSCO) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $52.00 price target on the stock. This represents a 5.5% upside from the current price of $49.27.
  • Deckers Outdoor (NYSE:DECK) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $960.00 price target on the stock. This represents a 11.9% upside from the current price of $857.81.
  • Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $44.00 price target on the stock. This represents a 83.3% upside from the current price of $24.01.
  • Eastman Chemical (NYSE:EMN) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $110.00 price target on the stock. This represents a 30.5% upside from the current price of $84.31.
  • Elastic (NYSE:ESTC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.The current price is $132.32.
  • GE HealthCare Technologies (NASDAQ:GEHC) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $100.00 price target on the stock. This represents a 18.1% upside from the current price of $84.67.
  • Monte Rosa Therapeutics (NASDAQ:GLUE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock. This represents a 114.4% upside from the current price of $5.13.
  • Immunovant (NASDAQ:IMVT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $55.00 price target on the stock. This represents a 45.8% upside from the current price of $37.72.
  • Insmed (NASDAQ:INSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock. This represents a 50.5% upside from the current price of $27.91.
  • JELD-WEN (NYSE:JELD) is now covered by analysts at Loop Capital. They set a "hold" rating and a $22.00 price target on the stock. This represents a 12.6% upside from the current price of $19.53.
  • Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $37.47.
  • MoonLake Immunotherapeutics (NASDAQ:MLTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $77.00 price target on the stock. This represents a 28.2% upside from the current price of $60.07.
  • Intellia Therapeutics (NASDAQ:NTLA) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $28.63.
  • RAPT Therapeutics (NASDAQ:RAPT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $39.00 price target on the stock. This represents a 53.6% upside from the current price of $25.39.
  • Roivant Sciences (NASDAQ:ROIV) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 47.8% upside from the current price of $11.50.
  • Skechers U.S.A. (NYSE:SKX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $73.00 price target on the stock. This represents a 21.0% upside from the current price of $60.33.
  • Super Micro Computer (NASDAQ:SMCI) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $1,040.00 price target on the stock. This represents a 6.9% upside from the current price of $973.18.
  • Savara (NASDAQ:SVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 61.3% upside from the current price of $4.96.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $515.00 price target on the stock. This represents a 21.2% upside from the current price of $424.78.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Elon Musk's "Project Dojo" is a Game-Changer
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...